EUVIMEDEUVIMED entdecken
Crossref

A Comparative Assessment of Interleukin-8 in Influenza, COVID19, and Asthma Cases

Ahlam Kadhum Abd, Mustafa Abdulkareem Salman, Naseer Hafedh Ibrahim

International Journal of Drug Delivery Technology · 05.05.2026 · 16 (24s)

DOI: 10.25258/ijddt.16.24s.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.05.2026. Verfasst von Ahlam Kadhum Abd und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging respiratory viruses are major health threats due to their potential to cause massive outbreaks. Infection with seasonal influenza, or COVID-19, Asthma may lead to respiratory failure may be due to local immune dysregulation like Cytokine storms are viewed as the driving force behind morbidity, such as interleukin 8 (IL-8), a pro-inflammatory cytokine that plays a role in neutrophil activation and has been linked to the pathogenesis and progression of these diseases. Methods: cohort study, conducted at the University of Diyala from 11/2023 to 6/2024. A total of 120 cases have been participated in our study, divided into 4 groups (healthy control, COVID-19, Seasonal flue, and Asthma patients). IL8 concentration was measured by using ELISA kit ELK-Biotechnology kit /CHINA.

Results

A male-to-female ratio of 71.6:28.3% and 63.3% of participants were over 40 years. IL-8 levels were highest in COVID-19 (598.80 pg/mL), followed by asthma (494.92 pg/mL) and influenza (362.99 pg/mL), with healthy individuals lowest (68.10 pg/mL). IL-8 distribution varied, with COVID-19 and asthma showing broader variability and higher correlations.

Conclusion

Interleukin-8 (IL-8) exhibits varying sensitivity and specificity across respiratory conditions, with limited utility as a standalone biomarker for influenza and COVID-19, high specificity but low sensitivity for asthma, and potential clinical value when considered alongside other biomarkers within the broader context of disease pathogenesis.

Zitieren

APA

Abd, A. K., Salman, M. A., & Ibrahim, N. H. (2026). A Comparative Assessment of Interleukin-8 in Influenza, COVID19, and Asthma Cases. International Journal of Drug Delivery Technology, 16(24s). https://doi.org/10.25258/ijddt.16.24s.49

Vancouver

Abd AK, Salman MA, Ibrahim NH. A Comparative Assessment of Interleukin-8 in Influenza, COVID19, and Asthma Cases. International Journal of Drug Delivery Technology. 2026;16(24s). doi:10.25258/ijddt.16.24s.49

BibTeX
@article{Abd2026,
  author = {Abd, Ahlam Kadhum and Salman, Mustafa Abdulkareem and Ibrahim, Naseer Hafedh},
  title = {A Comparative Assessment of Interleukin-8 in Influenza, COVID19, and Asthma Cases},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {24s},
  doi = {10.25258/ijddt.16.24s.49}
}
Kostenlos starten →